<6563> Mirai Works 1127 +26

Rally. Following the LDP leadership election held after the end of trading on the 27th, Shigeru Ishiba, who stated that he would implement a "large-scale regional revitalization policy," was elected as the new party leader, leading to buying pressure. The company is considered as part of the regional revitalization related efforts because it provides support for job transfers to local areas, operates a platform for matching side job talent for regional companies, plans workation tours for solving regional issues, and undertakes business commissioned by local governments.

<3692> FFRI 2399 -500

Hitting the daily price limit down. Following the election of Fumio Kishida over Sanae Takaichi in the runoff vote for the LDP presidential election held after the close of trading on the 27th, stocks are being sold. Prior to the election, there was significant buying in cybersecurity-related stocks on speculation that Takaichi, who emphasized cybersecurity defense strengthening, would win, hence the selling due to disappointment.

<9241> FLN 1922 +400

The stock price hit its daily limit. Following the Liberal Democratic Party leadership election held after the close of trading on the 27th, where Shigeru Ishiba stated that he would implement large-scale regional revitalization measures, he has been favored as the new party leader. The company established a new company called "Regional Activating AI Technologies" on the 2nd of this month, focusing on regional revitalization projects utilizing AI technology, development verification projects of advanced AI technology, and reskilling and learning projects centered around AI. It seems to be drawing attention as a combination of AI and regional revitalization.

<4978> Reprocell 121 -5

Decline. BioServe, a 100% subsidiary in India, announced the launch of the individual cancer genetic testing service 'PreciOnc' based on saliva in India, but it is falling due to the overall market conditions. BioServe has been providing cancer genetic testing services primarily to medical care facilities in the past. It aims to contribute to early detection of cancer and lifestyle improvement opportunities in India. Also, they consider home-based convenient cancer risk testing as a useful option for those who hesitate to seek medical treatment due to access and cost issues.

<4882> Perseus 552 -9

The stock fell. It was announced that the anti-transferrin receptor 1 antibody PPMX-T003, currently under development, was patented in Japan and initially rose but was pushed down by selling pressure due to market conditions. This patent is the result of a collaborative research with the research group of Professor Norio Komatsu, head of the Department of Internal Medicine at Juntendo University School of Medicine, and specifies the use for the treatment of true polycythemia among a series of patents for various cancers with PPMX-T003, with applications pending in other major countries besides Japan. The company aims to strengthen the intellectual property rights for a wide range of therapeutic applications of this antibody and already holds a material patent.

<3461> Palma 390 -2

Continued decline. Mitsubishi Estate announced the signing of a joint venture agreement and the acquisition of land for self-storage facility development. Mitsubishi Estate and jointly acquired the same property to develop and operate indoor self-storage facilities. Although the acquisition price was not disclosed, the amount of burden will be based on the proportion of the joint venture and will be less than 30% of the net assets in the fiscal year ending September 2023. By jointly promoting the business from the acquisition of the same property with Mitsubishi Estate, the two parties aim to improve the asset value of the property by mutually sharing their strengths. However, due to unfavorable market conditions, it continued to decline.